Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 12 (2024)

Patient and public involvement in academic clinical research in Switzerland – a mixed methods study

DOI
https://doi.org/10.57187/s.3563
Cite this as:
Swiss Med Wkly. 2024;154:3563
Published
06.12.2024

Summary

BACKGROUND: While patient and public involvement (PPI) in clinical research contributes substantially to research ethics, feasibility and quality, the uptake and implementation of PPI-based approaches in Switzerland remain unknown. This study aimed to evaluate the current state and acceptance of PPI in academic clinical research in Switzerland, with the goal of developing recommendations for its future implementation and development.

METHODS: A sequential explanatory mixed-methods study was conducted to assess the current landscape and acceptance of PPI in academic clinical research across different stakeholder groups in Switzerland. The groups were “Patients and Public”, “Researchers”, “Staff Members of Academic Research Infrastructure (ARI)” and representatives from “Regulatory and Funding Bodies”. Data was collected through a combination of surveys and semi-structured interviews. The survey results were analysed descriptively, while interview data was analysed qualitatively. The results were further synthesised into a SWOT (Strengths, Weaknesses, Opportunities and Threats) analysis.

RESULTS: A total of 123 survey responses were collected.Surveys revealed great support and acceptance for PPI in academic clinical research in Switzerland across all stakeholder groups. Despite this support, several challenges were identified, including gaps in training, limited funding opportunities and insufficient infrastructure to facilitate PPI.

CONCLUSION: The current framework for PPI in Switzerland is in an early stage of development. A joint effort by all stakeholders is needed to catch up with international progress to reach high-level ethical and quality standards. A basic framework for PPI in academic clinical research in Switzerland should be implemented, including guidelines for qualification and collaboration, best practices as well as widespread information for patients, the public and researchers. Further needed are training opportunities in “PPI in clinical research” for all stakeholders as well as sustainable sources of funding.

References

  1. Schilling I, Herbon C, Jilani H, Rathjen KI, Gerhardus A. [Patient and public involvement in clinical research: an introduction] [ZEFQ]. Z Evid Fortbild Qual Gesundhwes. 2020 Sep;155:56–63. doi: https://doi.org/10.1016/j.zefq.2020.06.007 DOI: https://doi.org/10.1016/j.zefq.2020.06.007
  2. Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res. 2014 Feb;14(1):89. doi: https://doi.org/10.1186/1472-6963-14-89 DOI: https://doi.org/10.1186/1472-6963-14-89
  3. Klingmann I, Heckenberg A, Warner K, Haerry D, Hunter A, May M, et al. EUPATI and patients in medicines research and development: guidance for patient involvement in ethical review of clinical trials. Front Med (Lausanne). 2018 Sep;5:251. doi: https://doi.org/10.3389/fmed.2018.00251 DOI: https://doi.org/10.3389/fmed.2018.00251
  4. Brett J, Staniszewska S, Mockford C, Herron-Marx S, Hughes J, Tysall C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014 Oct;17(5):637–50. doi: https://doi.org/10.1111/j.1369-7625.2012.00795.x DOI: https://doi.org/10.1111/j.1369-7625.2012.00795.x
  5. Crowe S, Fenton M, Hall M, Cowan K, Chalmers I. Patients’, clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch. Res Involv Engagem. 2015;1:1–10. DOI: https://doi.org/10.1186/s40900-015-0003-x
  6. Sacristán JA, Aguarón A, Avendaño-Solá C, Garrido P, Carrión J, Gutiérrez A, et al. Patient involvement in clinical research: why, when, and how. Patient Prefer Adherence. 2016 Apr;10:631–40. doi: https://doi.org/10.2147/PPA.S104259 DOI: https://doi.org/10.2147/PPA.S104259
  7. Kasenda B, von Elm E, You J, Blümle A, Tomonaga Y, Saccilotto R, et al. Prevalence, characteristics, and publication of discontinued randomized trials. JAMA. 2014 Mar;311(10):1045–51. doi: https://doi.org/10.1001/jama.2014.1361 DOI: https://doi.org/10.1001/jama.2014.1361
  8. Briel M, Elger B, von Elm E, Satalkar P. Insufficient recruitment and premature discontinuation of clinical trials in Switzerland: qualitative study with trialists and other stakeholders. Swiss Med Wkly. 2017 Nov;147:w14556. doi: https://doi.org/10.4414/smw.2017.14556 DOI: https://doi.org/10.4414/smw.2017.14556
  9. Nicolau B, Castonguay G, Levine A, Hong QN, Pluye P, Afrashtehfar KI, et al. Applied mixed methods in oral health research: importance and example of a training program. JDR Clin Trans Res. 2017;2(3):206–10. doi: https://doi.org/10.1177/2380084417705823 DOI: https://doi.org/10.1177/2380084417705823
  10. Varvasovszky Z, Brugha R. A stakeholder analysis. Health Policy Plan. 2000 Sep;15(3):338–45. doi: https://doi.org/10.1093/heapol/15.3.338 DOI: https://doi.org/10.1093/heapol/15.3.338
  11. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007 Oct;4(10):e296. doi: https://doi.org/10.1371/journal.pmed.0040296 DOI: https://doi.org/10.1371/journal.pmed.0040296
  12. Kotler P, Berger R, Bickhoff N. The Quintessence of Strategic Management - What You Really Need to Know to Survive in Business. The Quintessence of Strategic Management. Berlin, Heidelberg: Springer-Verlag; 2010. 10.1007/978-3-642-14544-5 DOI: https://doi.org/10.1007/978-3-642-14544-5
  13. Fergusson D, Monfaredi Z, Pussegoda K, Garritty C, Lyddiatt A, Shea B, et al. The prevalence of patient engagement in published trials: a systematic review. Res Involv Engagem. 2018 May;4(1):17. doi: https://doi.org/10.1186/s40900-018-0099-x DOI: https://doi.org/10.1186/s40900-018-0099-x
  14. Swiss Academy of Medical Sciences (SAMS). White Paper: Clinical Research. Swiss Academies Communications 16, (2021).
  15. Investigator initiated clinical trials (IICT). https://www.snf.ch/en/hyaJhBlfsmd618fO/funding/programmes/iict (2022).
  16. Amstutz A, Schandelmaier S, Frei R, Surina J, Agarwal A, Olu KK, et al. Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study. BMJ Open. 2017 Aug;7(7):e016216. doi: https://doi.org/10.1136/bmjopen-2017-016216 DOI: https://doi.org/10.1136/bmjopen-2017-016216
  17. Swiss Federal Council. Ordinance on Clinical Trials with Medical Devices of 1 July 2020 (Status as of 26 May 2021). (2020).
  18. Federal Office of Public Health. Teilrevision Des Ausführungsrechts Zum Bundesgesetz Über Die Forschung Am Menschen (HFG) - Erläuternder Bericht. (2023).
  19. Schweizerische Eidgenossenschaft. Patientenrechte und Patientenpartizipation in der Schweiz. Bericht in Erfüllung der Postulate 12.3100 Kessler, 12.3124 Gilli und 12.3207 Steiert. (2015).
  20. Eberle, D. & Hansen, M. M. B. PPI in Switzerland: A regulatory perspective. Regulatory Affairs Watch 4–7 (2021). DOI: https://doi.org/10.54920/SCTO.2021.RAWatch.6.4
  21. McKenzie A, Bowden J, Zalcberg JR, Conroy K, Fallon-Ferguson J, Jesudason S, et al. A snapshot of consumer engagement in clinical trials in Australia: results of a national survey of clinical trial networks and research organisations. Res Involv Engagem. 2022 Feb;8(1):3. doi: https://doi.org/10.1186/s40900-022-00338-w DOI: https://doi.org/10.1186/s40900-022-00338-w
  22. Tanemura, N., Sasaki, T., Sato, J. & Urushihara, H. Real World Survey of Patient Engagement Status in Clinical Research: The First Input from Japan. The Patient - Patient-Centered Outcomes Research 13, 623–632 (2020). DOI: https://doi.org/10.1007/s40271-020-00436-5
  23. NIHR - National Institute for Health Research. NIHR launches new Centre for Engagement and Dissemination. https://www.nihr.ac.uk/news/nihr-launches-new-centre-for-engagement-and-dissemination/24576 (2020).
  24. Canadian Institutes of Health Research. Strategy for Patient-Oriented Research. https://cihr-irsc.gc.ca/e/41204.html (2021).
  25. Patient-Centered Outcomes Research Institute. PCORI - Patient-Centered Outcomes Research Institute. https://www.pcori.org (2021).
  26. ICH Reflection paper. Proposed ICH Guideline Work to Advance Patient Focused Drug Development This. (2021).

Most read articles by the same author(s)